Search Results - "Digiesi, G"

A clinical case of occupational allergy to piperacilline. A novel diagnostic method: basophil activation test (BAT) by Marraccini, P, Digiesi, G, Pignatti, Patrizia, Bordini, L, Previdi, M

“…Piperacillin, unlike other antibiotics, rarely causes immediate allergic reactions. Only two cases related to occupational exposure are reported in the…”
Get more information

Clinicoprognostic implications of increased serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in early B-cell chronic lymphocytic leukaemia by MOLICA, S, VITELLI, G, LEVATO, D, RICCIOTTI, A, DIGIESI, G

“…To assess the relative merit of increased serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in predicting the risk of…”
Get full text

Vascular endothelial growth factor isoforms 121 and 165 are expressed on B-chronic lymphocytic leukemia cells by Molica, S, Santoro, R, Digiesi, G, Dattilo, A, Levato, D, Muleo, G

Get full text

202. Quantitative evaluation and optimization of daily on-line shift in prostate cancer treatment using control charts by Strolin, S., Ungania, S., Bruzzaniti, V., Rao, M., Montano, M., Digiesi, G., Sanguineti, G., Strigari, L.

“…Image-guided radiotherapy (IGRT) is daily used to correct patient setup errors based on the bony anatomy and soft-tissue contrast. When setup errors are larger…”
Get full text

The impact of fasting glucose on clinical-pathological features in epithelial ovarian cancer: results from a historic cohort by Barba, M., Pizzuti, L., Conti, L., Mandoj, C., Digiesi, G., Antenucci, A., Sergi, D., Di Lauro, L., Amodio, A., Carpano, S., Sperati, F., Valle, M., Garofalo, A., Vizza, E., Vincenzoni, C., Corrado, G., Maugeri-Saccà, M., Vici, P.

Get full text

Characterization of cytotoxic activity of saporin anti-gp185/HER-2 immunotoxins by Tecce, R, Digiesi, G, Savarese, A, Trizio, D, Natali, P G

“…The oncogene HER-2/neu encodes a trans-membrane receptor of 185 kDa with tyrosine-kinase activity. Over-expression of this molecule has been reported in a…”
Get more information

Timing of breast cancer surgery within the menstrual cycle: tumor proliferative activity, receptor status and short-term clinical outcome by Mangia, A, De Lena, M, Barletta, A, Marzullo, F, Attolico, M, Stea, B, Petroni, S, Labriola, A, Cellamare, G, Digiesi, G, Altieri, R, Schittulli, F, Paradiso, A

“…We verified the variations of primary tumour steroid receptor status and proliferative activity at different times and phases (follicular vs luteal) of the…”
Get more information

Immunohistochemical detection of high-affinity nerve growth factor receptor in neuroblastoma by Dominici, C., Nicotra, M.R., Digiesi, G., McDowell, H., Alemà, S., Padula, A., Gargano, N., Donfrancesco, A., Castello, M.A., Natali, P.G.

“…High levels of mRNA (as assessed by northern blot) for the high-affinity nerve growth factor receptor (p140 TRK) are predictive of favourable outcome in…”
Get full text

Prospects for the use of antioxidant therapy in hypertension by Digiesi, V, Lenuzza, M, Digiesi, G

“…The purpose of this review is to examine the indications and contraindications of antioxidant therapy in arterial hypertension. It has been suggested that…”
Get more information

Use of MoAb D612 in combination with a panel of MoAb for the immunocytochemical identification of metastases from colon-rectum carcinoma by MOTTOLESE, M, VENTURO, I, DIGIESI, G, PERRONE DONNORSO, R, BIGOTTI, A, MURARO, R, ALUFFI, A, NATALI, P. G

“…During the course of colon-rectum tumours a number of clinical events may occur in which conventional cytopathology can provide only a partial contribution to…”
Get full text

Increased serum levels of matrix metalloproteinase-9 predict clinical outcome of patients with early B-cell chronic lymphocytic leukaemia by Molica, Stefano, Vitelli, Gaetano, Levato, Domenico, Giannarelli, Diana, Vacca, Angelo, Cuneo, Antonio, Cavazzini, Franceso, Squillace, Roberto, Mirabelli, Rosanna, Digiesi, Giovanna

“…: Background and Methods: Serum levels of matrix metalloproteinase‐9 (MMP‐9) which agree with progression in solid and haematological tumours were correlated…”
Get full text

Clinicoprognostic implications of increased serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in early B-cell chronic lymphocytic leukaemia by Molica, S, Vitelli, G, Levato, D, Ricciotti, A, Digiesi, G

“…To assess the relative merit of increased serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in predicting the risk of…”
Get full text

Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression by Molica, Stefano, Vitelli, Gaetano, Levato, Domenico, Giannarelli, Diana, Vacca, Angelo, Cuneo, Antonio, Ribatti, Domenico, Digiesi, Giovanna

“…:  The association between angiogenin and cancer progression and poor outcome in solid tumors has been documented, but its significance in leukemias has not…”
Get full text

Shc products are substrates of erbB-2 kinase by Segatto, O, Pelicci, G, Giuli, S, Digiesi, G, Di Fiore, P P, McGlade, J, Pawson, T, Pelicci, P G

“…The shc genes encodes three widely expressed proteins of 46, 52 and 66 kDa. Overexpression of p46shc and p52shc in NIH3T3 fibroblasts induces a tumorigenic…”
Get more information

Expression of gp185HER-2 in human cutaneous melanoma: implications for experimental immunotherapeutics by Natali, P G, Nicotra, M R, Digiesi, G, Cavaliere, R, Bigotti, A, Trizio, D, Segatto, O

“…Over-expression of the HER-2 oncogene correlates with poor prognosis in breast and ovarian carcinomas. Using a sensitive immunohistochemical assay, we have…”
Get more information

Immunotoxins to the HER-2 oncogene product : functional and ultrastructural analysis of their cytotoxic activity by DI LAZZARO, C, DIGIESI, G, TECCE, R, LOTTI, L. V, TORRISI, M. R, NATALI, P. G

“…Two immunotoxins were prepared using monoclonal antibodies (mAb) directed towards two distinct epitopes of the gp185HER-2 extracellular domain, and the type I…”
Get full text

Production and characterization of murine mAbs to the extracellular domain of human neu oncogene product GP185HER2 by Digiesi, G, Giacomini, P, Fraioli, R, Mariani, M, Nicotra, M R, Segatto, O, Natali, P G

“…The oncogene HER-2/neu encodes a transmembrane glycoprotein of 185 kDa (gp185HER-2) with tyrosine-kinase activity. Gene amplification and high levels of…”
Get more information